Sonnet BioTherapeutics Ownership | Who Owns Sonnet BioTherapeutics?

Sonnet BioTherapeutics Ownership Summary

Sonnet BioTherapeutics is owned by 0.05% institutional investors, and 99.95% retail investors. Cinvest Azero Global FI is the top mutual fund, with 0.69% of its assets in Sonnet BioTherapeutics shares.

SONN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sonnet BioTherapeutics	0.05%	-	99.95%
Sector	Healthcare Stocks	46.80%	8.14%	45.06%
Industry	Biotech Stocks	44.70%	7.99%	47.31%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2022	1	-94.44%	2,000	-99.94%	-	0.00%	-	-100.00%	-	-100.00%
Jun 30, 2022	18	-14.29%	3,519,106	-41.21%	92	0.37%	6	-53.85%	6	100.00%
Mar 31, 2022	21	31.25%	5,985,793	50.03%	157	1.43%	13	62.50%	3	200.00%
Dec 31, 2021	16	23.08%	3,989,736	42.96%	105	1.95%	8	33.33%	1	-
Sep 30, 2021	13	30.00%	2,790,790	164.02%	73	9.49%	6	50.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Cinvest Azero Global FI	37.50K	0.69%	32.81K
Fidelity Extended Market Index	3.06K	0.06%	1.36K
Vanguard Institutional Extnd Mkt Idx Tr	1.84K	0.04%	-
Fidelity Series Total Market Index	348.00	0.01%	-
NT Ext Equity Mkt Idx Fd - L	92.00	0.00%	-
Northern Trust Extended Eq Market Idx	92.00	0.00%	-
SSgA U.S. Extended Market Index Class I	72.00	0.00%	-
State St US Extended Mkt Indx NL Cl C	8.00	0.00%	-1.00
SSgA U.S. Total Market Index Strategy	30.00	0.00%	9.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5	14.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 27, 2023	Rao Raghu	-	Buy	$25.00K
Oct 27, 2023	Rao Raghu	-	Buy	$50.00K
Oct 27, 2023	Mohan Pankaj	Chairman, President and CEO	Buy	$110.00K
Oct 27, 2023	Mohan Pankaj	Chairman, President and CEO	Buy	$55.00K
Jun 14, 2023	Dexter Susan	Chief Technical Officer	Buy	$7.00K

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	4	-
2023 Q3	-	-
2023 Q2	4	-
2023 Q1	1	-
2022 Q4	-	-

SONN Ownership FAQ

Who Owns Sonnet BioTherapeutics?

Sonnet BioTherapeutics shareholders are primarily institutional investors at 0.05%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sonnet BioTherapeutics's industry, Biotech Stocks , is 44.70%, which Sonnet BioTherapeutics falls below.

Does Blackrock own Sonnet BioTherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sonnet BioTherapeutics.

Who is the top mutual fund holder of Sonnet BioTherapeutics shares?

Cinvest Azero Global FI is the top mutual fund holder of Sonnet BioTherapeutics shares, with 0.69% of its total shares outstanding invested in 37.5K Sonnet BioTherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools